0001209191-23-044984.txt : 20230808 0001209191-23-044984.hdr.sgml : 20230808 20230808162356 ACCESSION NUMBER: 0001209191-23-044984 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230807 FILED AS OF DATE: 20230808 DATE AS OF CHANGE: 20230808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burgess Justin CENTRAL INDEX KEY: 0001812025 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 231151765 MAIL ADDRESS: STREET 1: C/O DYNAVAX TECHNOLOGIES CORPORATION STREET 2: 2100 POWELL STREET, SUITE 1900 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-07 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001812025 Burgess Justin C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 720 EMERYVILLE CA 94608 0 1 0 0 Chief Accounting Officer 0 Common Stock 2023-08-07 4 M 0 2528 5.42 A 2528 D Common Stock 2023-08-07 4 M 0 5533 9.41 A 8061 D Common Stock 2023-08-07 4 S 0 8061 14.545 D 0 D Stock Option (Right to Buy) 5.42 2023-08-07 4 M 0 2528 D 2027-02-11 Common Stock 2528 0 D Stock Option (Right to Buy) 9.41 2023-08-07 4 M 0 5533 D 2028-02-02 Common Stock 5533 2767 D This transaction was executed in multiple trades at prices ranging from $14.54 to $14.57; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax. This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 12. 2020, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter. Not applicable. This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 3, 2021, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter. /s/ Justin Burgess 2023-08-08